These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 9019932)

  • 1. [Autologous blood donation versus homologous blood transfusion--an analysis of cost effectiveness].
    Dietrich GV
    Zentralbl Chir; 1996; 121(10):841-6. PubMed ID: 9019932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cost analysis of autologous transfusion methods--a study of 5,017 patients].
    Singbartl G; Schleinzer W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Jun; 34(6):350-8. PubMed ID: 10429773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the cost of autologous erythrocyte concentrates in a hospital].
    Gouëzec H; Tardivel R; Danic B; Ballay JL; Malledant Y
    Cah Anesthesiol; 1996; 44(5):451-4. PubMed ID: 9183429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost effectiveness of preoperative autologous blood donations.
    Etchason J; Petz L; Keeler E; Calhoun L; Kleinman S; Snider C; Fink A; Brook R
    N Engl J Med; 1995 Mar; 332(11):719-24. PubMed ID: 7854380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of recombinant erythropoietin in surgery--are the costs justified?].
    Wolff M; Fandrey J; Jelkmann W; Hirner A
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():143-5. PubMed ID: 9101815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs associated with blood transfusions in Sweden--the societal cost of autologous, allogeneic and perioperative RBC transfusion.
    Glenngård AH; Persson U; Söderman C
    Transfus Med; 2005 Aug; 15(4):295-306. PubMed ID: 16101807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medical and cost efficiency of autologous blood donation in total hip or knee replacement].
    Willburger RE; Rüberg K; Knorth H; Casagranda O; Laubenthal H; Wiese M
    Z Orthop Ihre Grenzgeb; 2005; 143(3):360-4. PubMed ID: 15977128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cost analysis of autologous and allogeneic transfusions in hip-replacement surgery.
    Blumberg N; Kirkley SA; Heal JM
    Am J Surg; 1996 Mar; 171(3):324-30. PubMed ID: 8615466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous blood donation in cardiac surgery: reduction of allogeneic blood transfusion and cost-effectiveness.
    Dietrich W; Thuermel K; Heyde S; Busley R; Berger K
    J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):589-96. PubMed ID: 16202891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The societal unit cost of allogenic red blood cells and red blood cell transfusion in Canada.
    Amin M; Fergusson D; Wilson K; Tinmouth A; Aziz A; Coyle D; Hébert P
    Transfusion; 2004 Oct; 44(10):1479-86. PubMed ID: 15383022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative autologous blood donation - part I. Only two clinical parameters determine efficacy of the autologous predeposit.
    Singbartl G
    Minerva Anestesiol; 2007 Mar; 73(3):143-51. PubMed ID: 17384572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regarding the article "costs associated with blood transfusion in Sweden - the societal cost of autologous, allogeneic and perioperative RBC transfusion".
    Jidell E; Norda R; Berseus O; Swärd-Nilsson AM
    Transfus Med; 2006 Apr; 16(2):151-2; author reply 153. PubMed ID: 16623922
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cost-effectiveness analysis of an autotransfusion program in primary knee and hip replacement surgery].
    Díaz-Espallardo C; Moral-García V
    Rev Esp Anestesiol Reanim; 1999 Nov; 46(9):396-403. PubMed ID: 10613077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-benefit analysis of autologous blood donation in obstetrics.
    Combs CA; Murphy EL; Laros RK
    Obstet Gynecol; 1992 Oct; 80(4):621-5. PubMed ID: 1407883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A blood transfusion in Sweden--the societal cost].
    Glenngård AH; Persson U
    Lakartidningen; 2006 Sep 20-26; 103(38):2752-6. PubMed ID: 17058770
    [No Abstract]   [Full Text] [Related]  

  • 16. An economic analysis of costs associated with development of a cell salvage program.
    Waters JR; Meier HH; Waters JH
    Anesth Analg; 2007 Apr; 104(4):869-75. PubMed ID: 17377098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Heparin elimination and free hemoglobin following cell separation and washing of autologous blood with Cell Saver 4].
    Kling D; Börner U; von Bormann B; Hempelmann G
    Anasth Intensivther Notfallmed; 1988 Apr; 23(2):88-90. PubMed ID: 3394905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autologous blood donation with preservation by freezing].
    Höhne M
    Infusionstherapie; 1990 Apr; 17 Suppl 2():46-9. PubMed ID: 2373549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A new model for optimizing autologous transfusion by retrospective analysis of the transfusion requirement].
    Roos D; Kühnl P
    Beitr Infusionsther; 1990; 26():246-51. PubMed ID: 1703842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical study on the feasibility of autologous cord blood transfusion for anemia of prematurity.
    Khodabux CM; von Lindern JS; van Hilten JA; Scherjon S; Walther FJ; Brand A
    Transfusion; 2008 Aug; 48(8):1634-43. PubMed ID: 18507748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.